Adosopine
From Wikipedia, the free encyclopedia
This article needs more links to other articles to help integrate it into the encyclopedia. (June 2016) (Learn how and when to remove this template message) |
Names | |
---|---|
IUPAC name
N-(5-Methyl-6,11-dioxobenzo[c][1]benzazepin-10-yl)acetamide
|
|
Other names
Adosupine
|
|
Identifiers | |
88124-26-9 | |
3D model (Jmol) | Interactive image |
ChEMBL | ChEMBL2103994 |
ChemSpider | 59096 |
ECHA InfoCard | 100.081.230 |
PubChem | 65661 |
|
|
|
|
Properties | |
C17H14N2O3 | |
Molar mass | 294.31 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
Infobox references | |
Adosopine is a dibenzoazepine drug that has been studied for the treatment of urinary incontinence.[1][2]
References[edit]
- ^ Perico, A; Triolo, A; Viti, G; Mannucci, C; Caviglioli, G; Cocchini, A; Pestellini, V; Paoli, P; Dapporto, P (1994). "Synthesis, characterization, and analytical studies of adosupine, a potential new drug for urinary incontinence". Journal of pharmaceutical sciences. 83 (2): 137–42. doi:10.1002/jps.2600830206. PMID 8169779.
- ^ d'Aranno, V; Mancinelli, A; Manzini, S (1992). "Determination of the tricyclic compound adosupine and its three metabolites in plasma and brain of rat using high-performance liquid chromatography". Journal of Chromatography. 574 (2): 319–25. doi:10.1016/0378-4347(92)80046-s. PMID 1618966.
This article about an organic compound is a stub. You can help Wikipedia by expanding it. |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |